ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Immutep Ltd
$0.047
Day Range
$0.047 – $0.049
52 Week Range
$0.028 – $0.470
Volume
2.17M
Avg Volume (10D)
11.26M
Market Cap
$69.26M
Price Chart
Market Statistics
Open$0.047
Previous Close$0.047
Day High$0.049
Day Low$0.047
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap69.26M
Shares Outstanding1.47B
Price to Book0.72
Trading Activity
Volume2.17M
Value Traded103.55K
Bid$0.047 × 117,519
Ask$0.048 × 45,258
Performance
1 Day0.00%
5 Day-4.00%
13 Week-32.39%
52 Week-81.54%
YTD-88.43%
Technical Indicators
RSI (14)37.89
50-Day SMA$0.052
200-Day SMA$0.208
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]